Stock Research for UTHR

UTHR

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

UTHR Stock Chart & Research Data

The UTHR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the UTHR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


UTHR Due diligence Resources & Stock Charts

The UTHR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View UTHR Detailed Price Forecast - CNN Money CNN View UTHR Detailed Summary - Google Finance
Yahoo View UTHR Detailed Summary - Yahoo! Finance Zacks View UTHR Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View UTHR Trends & Analysis - Trade-Ideas Barrons View UTHR Major Holders - Barrons
NASDAQ View UTHR Call Transcripts - NASDAQ Seeking View UTHR Breaking News & Analysis - Seeking Alpha
Spotlight View UTHR Annual Report - CompanySpotlight.com OTC Report View UTHR OTC Short Report - OTCShortReport.com
TradeKing View UTHR Fundamentals - TradeKing Charts View UTHR SEC Filings - Bar Chart
WSJ View Historical Prices for UTHR - The WSJ Morningstar View Performance/Total Return for UTHR - Morningstar
MarketWatch View the Analyst Estimates for UTHR - MarketWatch CNBC View the Earnings History for UTHR - CNBC
StockMarketWatch View the UTHR Earnings - StockMarketWatch MacroAxis View UTHR Buy or Sell Recommendations - MacroAxis
Bullish View the UTHR Bullish Patterns - American Bulls Short Pains View UTHR Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View UTHR Stock Mentions - StockTwits PennyStocks View UTHR Stock Mentions - PennyStockTweets
Twitter View UTHR Stock Mentions - Twitter Invest Hub View UTHR Investment Forum News - Investor Hub
Yahoo View UTHR Stock Mentions - Yahoo! Message Board Seeking Alpha View UTHR Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for UTHR - SECform4.com Insider Cow View Insider Transactions for UTHR - Insider Cow
CNBC View UTHR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for UTHR - OTC Markets
Yahoo View Insider Transactions for UTHR - Yahoo! Finance NASDAQ View Institutional Holdings for UTHR - NASDAQ


Stock Charts

FinViz View UTHR Stock Insight & Charts - FinViz.com StockCharts View UTHR Investment Charts - StockCharts.com
BarChart View UTHR Stock Overview & Charts - BarChart Trading View View UTHR User Generated Charts - Trading View




Latest Financial News for UTHR


CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
Posted on Monday October 22, 2018

CollPlant (CLGN) (CLGN.TA) and United Therapeutics Corporation (UTHR) today announced that they have entered into a license, development and commercialization agreement for 3D bioprinted lung transplants. Under terms of the agreement, CollPlant granted United Therapeutics, through its wholly owned organ manufacturing and transplantation-focused subsidiary Lung Biotechnology PBC, an exclusive license to its technology for the production and use of rhCollagen-based BioInk for 3D bioprinted lung transplants throughout the universe. CollPlant will manufacture and supply BioInk for a few years to meet development process demand, and will provide technical support to United Therapeutics as it establishes a U.S. facility for the manufacture of CollPlant's rhCollagen and BioInk.


United Therapeutics (UTHR) Q3 Earnings Preview: What's in the Cards?
Posted on Wednesday October 17, 2018

United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.


Why MannKind Corp. Soared 16.4% Tuesday
Posted on Tuesday October 16, 2018

The company has completed its planned transaction with United Therapeutics.


United Therapeutics and MannKind Announce Closing of License and Collaboration Agreement
Posted on Tuesday October 16, 2018

United Therapeutics Corporation (UTHR) and MannKind Corporation (MNKD) today announced the closing of their pending worldwide exclusive license and collaboration agreement for the development and commercialization of Treprostinil Technosphere®, a dry powder formulation of treprostinil being developed for the treatment of pulmonary arterial hypertension. MannKind Corporation (MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension.  MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company's first FDA-approved product and the only inhaled rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.